Spinal muscular atrophy: clinical classification and disease heterogeneity
- PMID: 17761648
- DOI: 10.1177/0883073807305673
Spinal muscular atrophy: clinical classification and disease heterogeneity
Abstract
The clinical classification of spinal muscular atrophy, caused by deletion of the survival motor neuron 1 gene (SMN1), is based on age at onset and maximum function achieved. Evidence suggests that maximum function achieved is more closely related to life expectancy than age at onset. Therefore, it is important to wait for a period before assigning a patient to 1 of 5 classes of the disorder. Several diseases result from degeneration of the anterior horn cell but are not caused by SMN1. The classification for these conditions is evolving. This article offers an attempt at organizing one's thinking about this disease group.
Similar articles
-
Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests.Neurology. 2005 Nov 22;65(10):1631-5. doi: 10.1212/01.wnl.0000184506.61354.5b. Neurology. 2005. PMID: 16301493
-
Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy.Neuromuscul Disord. 2006 Dec;16(12):830-8. doi: 10.1016/j.nmd.2006.08.011. Epub 2006 Oct 17. Neuromuscul Disord. 2006. PMID: 17049859
-
Fishing for a mechanism: using zebrafish to understand spinal muscular atrophy.J Child Neurol. 2007 Aug;22(8):995-1003. doi: 10.1177/0883073807305671. J Child Neurol. 2007. PMID: 17761655 Review.
-
Investigation of the role of SMN1 and SMN2 haploinsufficiency as a risk factor for Hirayama's disease: clinical, neurophysiological and genetic characteristics in a Spanish series of 13 patients.Clin Neurol Neurosurg. 2007 Dec;109(10):844-8. doi: 10.1016/j.clineuro.2007.07.019. Epub 2007 Sep 11. Clin Neurol Neurosurg. 2007. PMID: 17850955
-
Spinal muscular atrophy diagnostics.J Child Neurol. 2007 Aug;22(8):952-6. doi: 10.1177/0883073807305668. J Child Neurol. 2007. PMID: 17761649 Review.
Cited by
-
Triptolide increases transcript and protein levels of survival motor neurons in human SMA fibroblasts and improves survival in SMA-like mice.Br J Pharmacol. 2012 Jun;166(3):1114-26. doi: 10.1111/j.1476-5381.2012.01829.x. Br J Pharmacol. 2012. PMID: 22220673 Free PMC article.
-
Neurofilament Phosphorylation during Development and Disease: Which Came First, the Phosphorylation or the Accumulation?J Amino Acids. 2012;2012:382107. doi: 10.1155/2012/382107. Epub 2012 Apr 18. J Amino Acids. 2012. PMID: 22570767 Free PMC article.
-
Natural history of lung function in spinal muscular atrophy.Orphanet J Rare Dis. 2020 Apr 10;15(1):88. doi: 10.1186/s13023-020-01367-y. Orphanet J Rare Dis. 2020. PMID: 32276635 Free PMC article.
-
Compensatory axon sprouting for very slow axonal die-back in a transgenic model of spinal muscular atrophy type III.J Physiol. 2017 Mar 1;595(5):1815-1829. doi: 10.1113/JP273404. Epub 2017 Jan 25. J Physiol. 2017. PMID: 27891608 Free PMC article.
-
Newborn screening facilitates early theranostics and improved spinal muscular atrophy outcome: five-year real-world evidence from Taiwan.Orphanet J Rare Dis. 2025 Apr 24;20(1):197. doi: 10.1186/s13023-025-03697-1. Orphanet J Rare Dis. 2025. PMID: 40275389 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical